Klaria Pharma Holding AB (publ.) reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported revenue was SEK 0.017 million compared to SEK 0.037 million a year ago. Net loss was SEK 16.11 million compared to SEK 15.21 million a year ago. Basic loss per share from continuing operations was SEK 0.27.
For the nine months, revenue was SEK 4.09 million compared to SEK 31.35 million a year ago. Net loss was SEK 50.88 million compared to SEK 14.43 million a year ago. Basic loss per share from continuing operations was SEK 0.88.